Market Place
Sourcing Support
All News #Library
Others
Oxford Biotherapeutics Collaborates With Bristol Myers Squibb
09 Apr 2026 //
GLOBENEWSWIRE
Oxford BioTherapeutics Named Best Tech SME At Thames Valley Awards
22 Jul 2024 //
GLOBENEWSWIRE
Oxford Bio Announces Launch of Enhanced Discovery Platform, OGAP®-Verify
07 Mar 2024 //
GLOBENEWSWIRE
Oxford BioTherapeutics Initiates Phase Ib Clinical Trial for OBT076
05 Jul 2023 //
GLOBENEWSWIRE
Boehringer Ingelheim extends 2020 collab with Oxford BioTherapeutics
25 May 2023 //
ENPTS
Oxford BioTherapeutics announces Phase 1b trial in collaboration with GORTEC
19 Apr 2023 //
GLOBENEWSWIRE
Oxford BioTherapeutics wins Tech Company of the Year
07 Mar 2023 //
GLOBENEWSWIRE
Oxford BioTherapeutics enters into Commercial License Agreement with Genmab
03 Oct 2022 //
PRNEWSWIRE
Oxford Bio Announces Research Collaboration with ImmunoGen to Develop Novel ADCs
13 Jun 2022 //
PRNEWSWIRE
Agenus Enters 3 New Clinical Collaborations
31 May 2022 //
CONTRACTPHARMA
Oxford Bio to Present Initial Positive Data from PI Trial at ASCO 2022
26 May 2022 //
PRNEWSWIRE
Oxford Bio Announces Collaboration with Agenus for OBT076 + Balstilimab
25 May 2022 //
PRNEWSWIRE
Oxford Bio to Present Potential Novel Mechanism with Checkpoint Inhibitors
07 Apr 2022 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.